跳至主要内容
临床试验/NCT03807986
NCT03807986Unknown不适用

The Combination Therapy of Nanofat Grafting and Platelet-Rich Plasma Injection Compared With Microfat Grafting and Platelet-Rich Plasma Injection Synergy in Treating Striae Distensae

First Affiliated Hospital of Jinan University1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2019年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
12
试验地点
1
主要终点
Immunohistochemical analysis

研究概览

简要总结

Striae distensae is caused by the fracture and damage of the elastic fibers and collagen fibers, which is still a difficulty to overcome. Based on the studies demonstrated that platelet-rich plasma(PRP) has positive effect on superficial scar, and nanofat and microfat are effective in treating atrophic scar. So in this clinical trial, the investigators are going to treat striae distensae by using two combination therapies. One is nanofat grafting and PRP injection synergy, and the other one is treated by microfat grafting with PRP injection.

详细描述

The participants were randomly assigned into two groups. Group A is treated by nanofat grafting once every three months for 2 times combined with PRP injection once a month for 6 times. Group B will be treated by microfat grafting onceevery three months for 2 times combined with PRP injection once a month for 6 times. The participants were asked to come back 1、3、6、9 months after treatment for further follow-up.Before and after the treatment, the striae distensae will be assessed subjectively by satisfaction assessment, and objectively by ultrasound and immunohistochemical analysis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Sequential
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • The striae distensae
  • Age ≤ 35 years old

排除标准

  • Skin allergy
  • Cicatricial diathesis
  • Skin inflammation or wound
  • Platelet dysfunction syndrome
  • Take anticoagulant drugs
  • Acute or chronic infection
  • Chronic liver disease
  • Active vitiligo, psoriasis, systemic lupus erythematosus

研究组 & 干预措施

Nanofat grafting and PRP injection

Experimental

Striae diatensae will be treated by nanofat grafting once every three months for 2 times combined with PRP injection once a month for 6 times.

干预措施: Nanofat grafting (Procedure)

Nanofat grafting and PRP injection

Experimental

Striae diatensae will be treated by nanofat grafting once every three months for 2 times combined with PRP injection once a month for 6 times.

干预措施: Platelet-rich plasma (PRP) Injection (Procedure)

Microfat grafting and PRP injection

Experimental

Striae diatensae will be treated by microfat grafting once every three months for 2 times combined with PRP injection once a month for 6 times.

干预措施: Microfat grafting (Procedure)

Microfat grafting and PRP injection

Experimental

Striae diatensae will be treated by microfat grafting once every three months for 2 times combined with PRP injection once a month for 6 times.

干预措施: Platelet-rich plasma (PRP) Injection (Procedure)

结局指标

主要结局

Immunohistochemical analysis

时间窗: Change from baseline at 15 months.

The tissue extracted will be taken for immunohistochemical analysis to observe the amount of elastic fiber and collagen fiber,etc. More collagen fiber generated better outcome of the treatments.

次要结局

  • Ultrasound(Change from baseline width of striae at 3,6,9,12,15 months of the treatments.)

研究者

发起方
First Affiliated Hospital of Jinan University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Li-Ling Xiao

Associate Chief of Department of Plastic Surgery

First Affiliated Hospital of Jinan University

研究点 (1)

Loading locations...

相似试验